DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy.
- Author:
Yihan PENG
1
;
Huadong PEI
2
Author Information
- Publication Type:Journal Article
- Keywords: AlkB homolog (ALKBH); Alkylation repair; Base excision repair; Methyl-guanine methyltransferase (MGMT)
- From: Journal of Zhejiang University. Science. B 2021;22(1):47-62
- CountryChina
- Language:English
- Abstract: Alkylated DNA lesions, induced by both exogenous chemical agents and endogenous metabolites, represent a major form of DNA damage in cells. The repair of alkylation damage is critical in all cells because such damage is cytotoxic and potentially mutagenic. Alkylation chemotherapy is a major therapeutic modality for many tumors, underscoring the importance of the repair pathways in cancer cells. Several different pathways exist for alkylation repair, including base excision and nucleotide excision repair, direct reversal by methyl-guanine methyltransferase (MGMT), and dealkylation by the AlkB homolog (ALKBH) protein family. However, maintaining a proper balance between these pathways is crucial for the favorable response of an organism to alkylating agents. Here, we summarize the progress in the field of DNA alkylation lesion repair and describe the implications for cancer chemotherapy.
